Skip to main content

Proceeding contribution from Baroness Tonge (Liberal Democrat) in the House of Lords on Tuesday, 4 December 2007. It occurred during Committee of the Whole House (HL) and Debate on bill on Human Fertilisation and Embryology Bill [HL].


Human Fertilisation and Embryology Bill [HL]

moved Amendment No. 29: 29: Schedule 2, page 55, line 16, leave out first ““abnormality”” and insert ““characteristic”” The noble Baroness said: I hope that this is a much briefer subject. It is another probing amendment, and I do not speak in any sort of dogmatic way. In embryo testing and sex selection, we feel that ““abnormality”” in these clauses is too restrictive. My understanding—and I have no experience of this—is that the characteristics of some cells, including genetic features, would occur in an otherwise healthy individual. Such a characteristic might lead to a serious risk of physical and mental disability. The example that I was given was of the apoprotein, which, if carried, gives an individual or even a family a higher risk of dementia or Alzheimer’s disease. The amendment is asking for information and for the Bill team to look at this carefully and ensure that, by using ““abnormality””, we are not excluding characteristics that might lead to disease, even though things are not abnormal at the time. This is a difficult distinction and may be semantics to some people, but it is worth looking at and I would like the Minister and the team to comment on it. I beg to move.


Secondary information

Type
Proceeding contribution
Reference
696 c1644-5 
Session
2007-08
Chamber / Committee
House of Lords chamber
Subjects
Abortion Fertility Human embryo experiments Donors Human Fertilisation and Embryology Authority Ethics IVF NHS Medical treatments Parents Organs Medicine Standards Training Screening Regulation Research Stem cells Christianity
Legislation
Human Fertilisation and Embryology Bill (HL) 2007-08
Link
View this Proceeding contribution on www.publications.parliament.uk